The Vitiligo Corporate Trench Map (Ep. 62)

The cavalry has finally arrived — but now you need a map. In this fast-paced Deep Dive in Vitiligo briefing, VRF CEO Yan Valle explores the forces reshaping the vitiligo landscape—from pharmaceutical giants and emerging biotech companies to AI-powered research, teledermatology, and the growing role of India and China in global innovation. Inside this episode: The Pioneers vs. The Giants: How a handful of early innovators opened the door for researchers and pharmaceutical companies. The Global Shift: Why the next wave of vitiligo innovation may be driven as much by India and China as by traditional biotech hubs. The Bulldozers Arrive: How companies like Incyte, AbbVie, and Pfizer changed the field from a fragile research niche into a serious dermatology market. For years, the biggest challenge was getting vitiligo noticed. Today, the challenge is knowing where to go next. We have officially entered the Era of Navigation. If you want a clearer picture of where the science, the investment, and the opportunities are moving, this episode is your map.   📚 Prefer reading to listening? The full companion article, “The Vitiligo Corporate Trench Map,” is available on the VRF website and expands on many of the themes discussed in this episode.